HCRS logo
 

Hot Links

PubMed CORDIS ClinicalTrials.Gov National Institute for Health and Clinical Excellence Hellenic Cardiological Society Greek National Documentation Centre Hellenic Ministry of Development - General Secretariat for Research and Technology

Administration

Back Up one level

The Society's administrative bodies are as follows:

  • General Assembly
  • Board
  • Executive Committee
  • Audit Committee

The General Assembly, which includes all paid-up members of the Society, is the highest level administrative body. It decides on all major matters relating to the Society, as and when required, and it does not answer to any other body. Decisions of the General Assembly are binding on both the members and the administration of the Society. The General Assembly monitors the Board of the Society and its other administrative and functional bodies. The responsibilities of the General Assembly are described in detail in the Society's statutes. The General Assembly convenes annually, in January, at a meeting organised by the Board.

The Board of the Society has nine members and is elected by the General Assembly for a three-year term. Its composition is as follows:

  • President
  • Past President
  • Vice President
  • Secretary
  • Treasurer
  • Counsellors (4)

If there is no Past President, or if the Past President wishes to be re-elected or does not wish to participate in the Board, five Counsellors will be elected.

The Executive Committee has three members: the President and two members of the Board.

The Audit Committee monitors the Board with respect to financial management. It has four members and is elected by the General Assembly.

Back Up one level

 

Go to top Top of page

CRF_button
CRF_button

HCRS BROCHURE

Hot Articles

  1. Assali A, Vaduganathan M, Vaknin-Assa H et al. Comparison of Late (3-Year) Registry Data Outcomes Using Bare Metal Versus Drug-Eluting Stents for Treating ST-Segment Elevation Acute Myocardial Infarctions. Am. J. Cardiol. 2012; 109:1563-1568 … more More
  2. Martinoni A, De Servi S, Politi A et al. Defining high-risk patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention: A comparison among different scoring systems and clinical definitions. Int. J. Cardiol. 2012; 157:207-211 … more More
  3. Schirmer SH, Degen A, Baumhäkel M et al. Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis. Eur Heart J 2012; 33: 1223-1231 … more More
  4. Patel VB, Bodiga S, Basu R et al. Loss of Angiotensin-Converting Enzyme-2 Exacerbates Diabetic Cardiovascular Complications and Leads to Systolic and Vascular Dysfunction: A Critical Role of the Angiotensin II/AT1 Receptor Axis. Circulation Research 2012;110 1322-1335 … more More
  5. Aversano T., Lemmon C.C., Liu L. Outcomes of PCI at hospitals with or without On-Site Cardiac Surgery. N Engl J Med 2012; 366:1792-1802 … more More
  6. Selker HP, Beshansky JR, Sheehan PR et al. Out-of-Hospital Administration of Intravenous Glucose-Insulin-Potassium in Patients With Suspected Acute Coronary Syndromes: The IMMEDIATE Randomized Controlled Trial. JAMA 2012;307(18):1925-1933 … more More
  7. Cheng S, Rhee ER, Larson MG et al. Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans. Circulation 2012;125 : 2222-2231 … more More
  8. Berkowitch A, Kuniss M, Greiss H et al. Impact of Impaired Renal Function and Metabolic Syndrome on the Recurrence of Atrial Fibrillation after Catheter Ablation: A Long Term Follow-Up. PACE 2012; 35:532–543 … more More
  9. McEntegart MB, Kirtane AJ, Cristea E et al. Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Are Associated With Adverse Outcomes: Analysis From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial. J Am Coll Cardiol 2012;59: 1745-1751 … more More
  10. Murtagh G, Dawkins IR, O'Connell R et al. Screening to prevent heart failure (STOP-HF): expanding the focus beyond asymptomatic left ventricular systolic dysfunction. Eur J Heart Fail 2012; 14: 480-486 … more More

Sign up for our newsletter:

Name:

Email: